Clarity Pharmaceuticals Closes $10 million Capital Raising
Sydney, Australia 8 May 2019 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed its anticipated capital raising of $10,000,005.50. This includes the previously announced strategic investment of $5,000,002.75 from GenesisCare, the largest private provider of cancer treatment in Australia and Europe, an…